{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:58:53Z","timestamp":1792699133459,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.biologicals.2023.101698","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T05:13:48Z","timestamp":1691471628000},"page":"101698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Stability of lyophilized Meningococcal A conjugate vaccine, (MenAfriVac\u2122) at elevated temperatures to support controlled temperature chain (CTC) claim"],"prefix":"10.1016","volume":"83","author":[{"given":"Sunil","family":"Gairola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2023.101698_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson lecture. Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2023.101698_bib2","doi-asserted-by":"crossref","first-page":"A97","DOI":"10.1016\/j.vaccine.2007.04.049","article-title":"The meningitis vaccine project","volume":"25S","author":"LaForce","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2023.101698_bib3","doi-asserted-by":"crossref","unstructured":"Carle E. Frasch Recent developments in Neisseria meningitidis group A conjugate vaccines. Expet Opin Biol Ther. Pages 273-280.","DOI":"10.1517\/14712598.5.2.273"},{"key":"10.1016\/j.biologicals.2023.101698_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-415766-8.00004-5","article-title":"Elena A. Varavikova communicable diseases","volume":"149\u2013236","author":"Tulchinsky","year":"2014","journal-title":"The New Public Health"},{"issue":"5","key":"10.1016\/j.biologicals.2023.101698_bib5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/21645515.2017.1412020","article-title":"Vaccine prevention of meningococcal disease in Africa: major advances, remaining challenges","volume":"14","author":"Mustapha","year":"2018","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2023.101698_bib6","article-title":"Introduction and rollout of a new group A meningococcal conjugate vaccine (PsA-TT) in african meningitis belt countries","author":"Djingarey","year":"2015","journal-title":"2010-2014 Clinical infectious diseases"},{"issue":"5","key":"10.1016\/j.biologicals.2023.101698_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2471\/BLT.11.030511","article-title":"Vaccination: rattling the supply chain","volume":"89","author":"Humphreys","year":"2011","journal-title":"World Health Organization"},{"issue":"1","key":"10.1016\/j.biologicals.2023.101698_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4161\/hv.3.1.3749","article-title":"Long-term thermal stability of group C meningococcal polysaccharide-tetanus toxoid conjugate","volume":"3","author":"Lee","year":"2007","journal-title":"Human Vaccines Jan-Feb"},{"key":"10.1016\/j.biologicals.2023.101698_bib9","author":"Milstien","year":"2014"},{"key":"10.1016\/j.biologicals.2023.101698_bib10","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.supp.2017.27.3.12087","article-title":"An economic evaluation of the controlled temperature chain approach for vaccine logistics: evidence from a study conducted during a meningitis A vaccine campaign in Togo","volume":"27","author":"Mvundura","year":"2017","journal-title":"The Pan African Medical Journal"},{"key":"10.1016\/j.biologicals.2023.101698_bib11","unstructured":"International Conference on Harmonized Tripartite Guideline.Stability testing of new drug substances and product. (Q1A [R2]) (Q5C [R2]) current step 4 version dated 6 february 2003."},{"key":"10.1016\/j.biologicals.2023.101698_bib12","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1021\/ac60119a033","article-title":"Micro determination of phosphorous","volume":"28","author":"Chen","year":"1956","journal-title":"Anal Chem"},{"issue":"1","key":"10.1016\/j.biologicals.2023.101698_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/biol.1997.0121","article-title":"A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophilus influenzae type b in PRP-tetanus toxoid conjugate vaccine","volume":"26","author":"Guo","year":"1998","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2023.101698_bib14","first-page":"259","article-title":"Quantification of free polysaccharide in meningococcal polysaccharide -diphtheria toxoid conjugate vaccine","volume":"103","author":"Lei","year":"2000","journal-title":"Dev Biologicals"},{"issue":"2","key":"10.1016\/j.biologicals.2023.101698_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0264-410X(98)00166-2","article-title":"A routine high performance size-exclusion chromatography to determine molecular size distribution of Haemophilus influenzae type b conjugate vaccines","volume":"17","author":"Von Hunolstein","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2023.101698_bib16","article-title":"MenAfrivac Stability Assessment Report (Unpublished data) Feasibility for use of the meningococcal A conjugate vaccine in a controlled temperature chain","volume":"6","year":"2012","journal-title":"Center for vaccine Evolution Biologics and Genetic Therapies Directorate Health Products and Food Branch June"},{"issue":"4","key":"10.1016\/j.biologicals.2023.101698_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/vaccines10040617","article-title":"Simonetta viviani efficacy and effectiveness of the meningococcal conjugate group A vaccine MenAfriVac \u00ae in preventing recurrent meningitis epidemics in sub-saharan Africa","volume":"10","year":"2022","journal-title":"Vaccines"},{"issue":"13","key":"10.1016\/j.biologicals.2023.101698_bib18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.vaccine.2014.01.038","article-title":"Benefits of using vaccines out of the cold chain: delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin","volume":"32","author":"Zipursky","year":"2014","journal-title":"Journal Vaccine"},{"key":"10.1016\/j.biologicals.2023.101698_bib19","unstructured":"World Health Organization, Recommendation to assure the quality, safety and efficacy of group A meningococcal conjugate vaccines. Technical series no. 962 Annex 2, WHO Expert committee on biological standardization fifty seventh report 2011 Geneva.http:\/\/www.who.int\/biologicals\/vaccines\/Annex_2_WHO_TRS_962."}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105623000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105623000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:16:00Z","timestamp":1760922960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105623000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":19,"alternative-id":["S1045105623000362"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2023.101698","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability of lyophilized Meningococcal A conjugate vaccine, (MenAfriVac\u2122) at elevated temperatures to support controlled temperature chain (CTC) claim","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2023.101698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101698"}}